A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections



Document title: A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections
Journal: The brazilian journal of infectious diseases
Database: PERIÓDICA
System number: 000290737
ISSN: 1413-8670
Authors: 1





Institutions: 1Universidade Federal da Bahia, Hospital Prof. Edgar Santos, Salvador, Bahia. Brasil
Year:
Season: Oct
Volumen: 6
Number: 5
Pages: 206-218
Country: Brasil
Language: Inglés
Document type: Artículo
Approach: Caso clínico, analítico
English abstract The safety and efficacy of cefepime empiric monotherapy compared with standard broad-spectrum combination therapy for hospitalized adult patients with moderate to severe community-acquired bacterial infections were evaluated. In an open-label, multicenter study, 317 patients with an Acute Physiology and Chronic Health Evaluation (APACHE II) score ranging from >5 to =19 were enrolled with documented pneumonia (n=196), urinary tract infection (n=65), intra-abdominal infection (n=38), or sepsis (n=18). Patients were randomly assigned 1:1 to receive cefepime 1 to 2 g IV twice daily or three times a day or IV ampicillin, cephalothin, or ceftriaxone ± aminoglycoside therapy for 3 to 21 days. For both treatment groups, metronidazole, vancomycin, or macrolide therapy was added as deemed necessary. The primary efficacy variable was clinical response at the end of therapy. Two hundred ninety-six (93%) patients met evaluation criteria and were included in the efficacy analysis. Diagnoses included the following: 180 pneumonias (90 cefepime, 90 comparator), 62 urinary tract infections (29 cefepime, 33 comparator), 37 intra-abdominal infections (19 cefepime, 18 comparator), and 17 sepses (8 cefepime, 9 comparator). At the end of therapy, overall clinical success rates were 131/146 (90%) for patients treated with cefepime vs 125/150 (83%) for those treated with comparator (95% confidence interval [CI]: - 2.6% to 16.3%). The clinical success rate for patients with community-acquired pneumonia, the most frequent infection, was 86% for both treat
Disciplines: Medicina
Keyword: Farmacología,
Microbiología,
Terapéutica y rehabilitación,
Cefepima,
Ampicilina,
Caphalotin,
Infecciones,
Vías urinarias,
Sepsis
Keyword: Medicine,
Microbiology,
Pharmacology,
Therapeutics and rehabilitation,
Cefepime,
Ampicillin,
Caphalotin,
Infections,
Urinary tract,
Sepsis
Full text: Texto completo (Ver HTML)